Position in GPCR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$76,883,831
+$7,835,934 QoQ
Shares Held
1,432,529
0.0% QoQ
Ownership
2.01%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#13
of 190 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAKER BROS. ADVISORS LP holds $18,875,530,286 across 78 Biotechnology names. GPCR ranks #28 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
30,762,330 | $3,487,217,728 | |
| 2 | ONC |
BeOne Medicines Ltd.
|
8,801,567 | $2,508,182,547 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
11,443,357 | $2,143,111,898 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,143,131 | $1,150,754,190 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
42,912,904 | $1,085,696,471 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
8,657,242 | $992,725,940 | |
| 7 | INSM |
INSMED Inc
|
8,796,111 | $937,841,354 | |
| 8 | CELC |
Celcuity Inc.
|
7,915,792 | $828,150,159 |
All Filings in GPCR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,883,831 | 1,432,529 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $69,047,897 | 1,432,529 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $99,632,391 | 1,432,529 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $43,571,052 | 1,556,109 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $52,031,827 | 2,508,767 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,258,690 | 361,565 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,805,642 | 361,565 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,752,595 | 85,500 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||